Table 5.
Self-reported Adverse events in vaccinated participants.
| Variables |
Dose 1, n (%) |
Dose 2, n (%) |
Both, n (%) |
|---|---|---|---|
| Self-reported Adverse events | |||
| Completed the first dose (n = 2,016) | 433 (21.5) | - | - |
| Completed the second dose (n = 1,918) | 419 (21.9) | 396 (20.7) | 284 (14.8) |
| Adverse events requiring treatment | |||
| Completed the first dose (n = 2,016) | 17 (0.8) | ||
| Completed the second dose (n = 1,918) | 15 (0.8) | 13 (0.7) | 6 (0.3) |
| Adverse events affecting life | |||
| Completed the first dose (n = 2,016) | 29 (1.4) | ||
| Completed the second dose (n = 1,918) | 26 (1.4) | 23 (1.2) | 12 (0.6) |